Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Chromatin
AddedFeb 15, 2024
UpdatedJun 18, 2026
Chromatin

Chromatin

Chromatin: Innovating biotech solutions for agriculture and energy, enhancing productivity and value.

HQ
Chicago, IL, US
Founded
2001
Overview
Compare
Fundraising
Employees
Website

Founded with a vision to revolutionize the agricultural and energy sectors, Chromatin is a biotech company that leverages gene stacking technology to develop innovative solutions. The company's core mission is to unlock the potential of plants to produce greater value for consumers, growers, seed producers, and bioprocessors. Chromatin offers products and technologies that address key societal challenges, including improving agricultural productivity and increasing renewable energy sources.

Chromatin has garnered attention for its pioneering work in the biotech industry, attracting notable investors and partnerships. The company has achieved significant milestones in commercializing its gene stacking technology, which has broad applications across agriculture, energy, chemical, nutritional, and pharmaceutical sectors. Through its innovative solutions, Chromatin has made a substantial impact on enhancing productivity and sustainability in various industries.

Chromatin - Similar Companies

Plastomics logo

Plastomics

plastomics.com

Chi Botanic logo

Chi Botanic

chibotanic.com

Agradis logo

Agradis

Agragene logo

Agragene

agragene.com

Chroma Medicine logo

Chroma Medicine

Geneshifters logo

Geneshifters

Genoverde Biosciences logo

Genoverde Biosciences

genoverde.com

Botanisol Analytics logo

Botanisol Analytics

Biodel logo

Biodel

biodelag.com

Cellibre logo

Cellibre

cellibre.com

EpiCypher logo

EpiCypher

epicypher.com

Front Range Biosciences logo

Front Range Biosciences

frontrangebio.com

AgroSpheres logo

AgroSpheres

agrospheres.com

TerMir logo

TerMir

Phylos logo

Phylos

Chromatin - Quick Facts

Who are Chromatin's competitors?

Companies similar to Chromatin include Plastomics, Chi Botanic, Agradis and Agragene.

When was Chromatin founded?

Chromatin was founded in 2001.

Where is Chromatin's headquarters located?

Chromatin's headquarters is located in Chicago, IL, US.

When was Chromatin's last funding round?

Chromatin's most recent funding round was for $13.7M (USD) in May 2017.

How much has Chromatin raised to-date?

As of May 24, 2017, Chromatin has raised a total of $122.3M (USD).

How many employees does Chromatin have?

Chromatin has 75 employees as of Feb 4, 2024.

Chromatin - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Licensing
  • Recurring
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Agricultural Products
Tags
  • AgTech
NAICS
  • 220000Utilities
  • 221000Utilities
SIC
  • 1300Oil And Gas Extraction
  • 1380Oil And Gas Field Services
  • 1382Oil And Gas Field Exploration Services